LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Aesculap: 100% Survivorship at Five-Years
Large Joints and Extremities

Aesculap: 100% Survivorship at Five-Years

September 27, 2013 2 min read Premium comments

Advertisement

Aesculap: 100% Survivorship at Five-Years
Aesculap Implant Systems / Courtesy: Aesculap Implant Systems, LLC
Secondary

Aesculap Implant Systems, LLC has announced its sponsorship of a clinical study focused on furthering the science of navigated total knee arthroscopy (TKA) as a proven method for improved alignment accuracy and reproducibility of the surgical technique. Aesculap Implant Systems OrthoPilot Navigation System and the Columbus Knee System were featured in the study that showed a 100% survivorship at five years post-op when compared with other non-navigated TKA.

The Columbus Navigated TKA Clinical Study states that the major factors for a favorable long-term clinical and functional outcome after conventional TKA are based on correct implant positioning and restoration of the mechanical axis and soft tissue balancing to reduce aseptic loosening. The use of computer-assisted tools for TKA allows more accurate and reproducible positioning and alignment of TKA components compared with conventional techniques.

The researchers set out to analyze data from a minimum five-year follow-up of navigated TKA to determine the intra-operative alignment and stability measurements, the functional outcomes and survival rates of high-flexion, high-conformity unresurfaced patella TKA and the range of motion (ROM) of the high-flexion TKA system during the study period.

The Columbus Navigated TKA study is a retrospective analysis of 100 consecutive patients who received primary patella-sparing TKA. At five years post-op, mid-term TKA survival rate, clinical and radiological outcomes, and visual analog scale (VAS) pain and satisfaction scores were analyzed. Some key study findings were:

  • The results at five years revealed a component revision rate of 0% compared with other non-navigated TKAs (2.8% revision rate)
  • Mean KSS and OKI scores improved by more than 45%
  • VAS scores improved and final mean VAS satisfaction scores had 91% of patients with scores in the good to excellent range
  • The authors used navigation tools to keep the components aligned in the mechanical axis of 0° ±1.14° in all cases with stable balanced soft tissue

The key finding of the study showed a 100% survivorship at five-years post-op when compared with other non-navigated TKA. The study also revealed an improved ROM from 95º preoperatively to 110º postoperatively.

Uta Giordano, director of Orthopaedic Marketing for Aesculap, told OTW, “The results of this study confirm that the Columbus Knee System used in conjunction with the OrthoPilot Navigation System improve alignment accuracy and reproducibility of the total knee arthroplasty surgical technique. Our goal is to use these clinical results to improve patient outcomes with this solution.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy